Sandoz Prepares For European Natalizumab Launch As Approval Arrives

Company Offers Indications Of Launch Timing For Tyruko Biosimilar Rival To Tysabri

 
• By David Wallace
Europe by night, seen from space
Sandoz is getting ready to launch natalizumab in Europe • Source: Shutterstock

More from Biosimilars

More from Products